Clinical Trials Directory

Trials / Completed

CompletedNCT04594083

Two Different Tactile Stimulus Methods

A Comparison of Two Different Tactile Stimulus Methods on Reducing Pain

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
159 (actual)
Sponsor
Adiyaman University Research Hospital · Academic / Other
Sex
All
Age
7 Years – 10 Years
Healthy volunteers
Accepted

Summary

This study was conducted to evaluate the effects of the ShotBlocker and Palm Stimulator, developed by researchers for reducing pain during intramuscular (IM) injections in children.

Detailed description

Objectives: This study was conducted to evaluate the effects of the ShotBlocker and Palm Stimulator, developed by researchers for reducing pain during intramuscular (IM) injections in children. Design: The study was conducted via a randomized controlled design. Setting: The study population consisted of children in the seven to 10 age group admitted to the emergency department of a public hospital (Kahta State Hospital) between February 2019 and July 2019 and who received an IM injection as part of the medical treatment. Interventions: The study data were collected from the children, who were divided into Palm Stimulator, ShotBlocker, and control groups. Main outcome measures: The children's pre-procedure fear levels were evaluated using the Children's Fear Scale (CFS), and their pain levels during the procedure were evaluated using the Facial Pain Scale-Revised (FPS-R). The children also reported injection-related pain levels using the Visual Analog Scale (VAS).

Conditions

Interventions

TypeNameDescription
DEVICEPalm StimulatorThe Palm Stimulator, developed by the present researchers for the first time, is 1.6 cm in diameter, 4 cm in length, and has a cylindrical, non-slippery structure for an easy grip to ensure maximum contact with the palm The Palm Stimulator consists of blunt protrusions that will provide a tactile stimulus on the palm. The blunt protrusions do not penetrate into the skin. The simulator design is based on the gate-control theory, which allows for a reduction in the perceived amount of pain experienced during injection by closing the pain gate in the spinal cord in creating a stimulus on the skin.
DEVICEShotBlockerShotBlocker was placed in the ventrogluteal area properly 20 seconds before injection. It was fixed at the injection site until the injection process was completed.

Timeline

Start date
2019-02-01
Primary completion
2019-07-01
Completion
2020-02-07
First posted
2020-10-20
Last updated
2021-01-14

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04594083. Inclusion in this directory is not an endorsement.